Mellah et al., 2022 - Google Patents
New Cocrystallization Method: Non-photochemical Laser-Induced Nucleation of a Cocrystal of Caffeine–Gallic Acid in WaterMellah et al., 2022
View PDF- Document ID
- 9579310706064830061
- Author
- Mellah D
- Nicolaï B
- Fournier B
- Bošnjaković-Pavlović N
- Legrand F
- Gemeiner P
- Boemare V
- Guiblin N
- Assi A
- Tfayli A
- Konate S
- Durand P
- Spasojević-de Biré A
- Publication year
- Publication venue
- Crystal Growth & Design
External Links
Snippet
This paper reports for the first time the crystallization of cocrystals (caffeine–gallic acid) in water using the non-photochemical laser-induced nucleation (NPLIN) technique. The nucleation temporal control of NPLIN and the induction time reduction (70 times shorter than …
- 238000010899 nucleation 0 title abstract description 168
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thayyil et al. | Pharmaceutical co-crystallization: Regulatory aspects, design, characterization, and applications | |
| Higashi et al. | Recent progress of structural study of polymorphic pharmaceutical drugs | |
| Fischer et al. | Polymorphism of mechanochemically synthesized cocrystals: a case study | |
| Chow et al. | Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide | |
| Laitinen et al. | Emerging trends in the stabilization of amorphous drugs | |
| Gao et al. | Coformer selection based on degradation pathway of drugs: A case study of adefovir dipivoxil–saccharin and adefovir dipivoxil–nicotinamide cocrystals | |
| Fischer et al. | Supply and demand in the ball mill: competitive cocrystal reactions | |
| Kumari et al. | Enhancing the pharmaceutical properties of pirfenidone by mechanochemical cocrystallization | |
| Grifasi et al. | Using salt cocrystals to improve the solubility of niclosamide | |
| Arenas-Garcia et al. | Co-crystals of active pharmaceutical ingredients-acetazolamide | |
| Heng et al. | Incorporation of complexation into a coamorphous system dramatically enhances dissolution and eliminates gelation of amorphous lurasidone hydrochloride | |
| Mellah et al. | New Cocrystallization Method: Non-photochemical Laser-Induced Nucleation of a Cocrystal of Caffeine–Gallic Acid in Water | |
| Skorupska et al. | Thermal solvent-free method of loading of pharmaceutical cocrystals into the pores of silica particles: A Case of naproxen/picolinamide cocrystal | |
| Hossain Mithu et al. | Advanced methodologies for pharmaceutical salt synthesis | |
| Dayo Owoyemi et al. | Fluconazole: synthesis and structural characterization of four new pharmaceutical cocrystal forms | |
| Sevukarajan et al. | Synthesis and characterization of a pharmaceutical co-crystal:(aceclofenac: nicotinamide) | |
| Rajbongshi et al. | Preparation of pyrazinamide eutectics versus cocrystals based on supramolecular synthon variations | |
| Vangala et al. | Thermal and in situ X-ray diffraction analysis of a dimorphic co-crystal, 1: 1 caffeine–glutaric acid | |
| Sathisaran et al. | Cocrystallization of carbamazepine with amides: Cocrystal and eutectic phases with improved dissolution | |
| Bolla et al. | Pentamorphs of acedapsone | |
| Lin | Mechanochemical approaches to pharmaceutical cocrystal formation and stability analysis | |
| Yadav et al. | Cocrystals: A complete review on conventional and novel methods of its formation and its evaluation | |
| Nascimento et al. | Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement | |
| Khanfar et al. | Preparation and evaluation of co-amorphous formulations of telmisartan—amino acids as a potential method for solubility and dissolution enhancement | |
| Cho et al. | Preparation and characterization of aripiprazole cocrystals with coformers of multihydroxybenzene compounds |